BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3796692)

  • 1. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.
    Ratliff NB; Estes ML; Myles JL; Shirey EK; McMahon JT
    N Engl J Med; 1987 Jan; 316(4):191-3. PubMed ID: 3796692
    [No Abstract]   [Full Text] [Related]  

  • 2. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.
    Soong TR; Barouch LA; Champion HC; Wigley FM; Halushka MK
    Hum Pathol; 2007 Dec; 38(12):1858-63. PubMed ID: 18061791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine: a treatable cause of cardiomyopathy.
    Abbasi S; Tarter L; Farzaneh-Far R; Farzaneh-Far A
    J Am Coll Cardiol; 2012 Aug; 60(8):786. PubMed ID: 22898072
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.
    Keating RJ; Bhatia S; Amin S; Williams A; Sinak LJ; Edwards WD
    J Am Soc Echocardiogr; 2005 Sep; 18(9):981. PubMed ID: 16153529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine-induced cardiomyopathy: a case report.
    Muthukrishnan P; Roukoz H; Grafton G; Jessurun J; Colvin-Adams M
    Circ Heart Fail; 2011 Mar; 4(2):e7-8. PubMed ID: 21406675
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI.
    Hanneman K; Alberdi HV; Karur GR; Tselios K; Harvey PJ; Gladman DD; Akhtari S; Osuntokun T; Wald RM; Thavendiranathan P; Butany J; Urowitz MB
    JACC Cardiovasc Imaging; 2020 Mar; 13(3):879-881. PubMed ID: 31734202
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter by Pieroni et al regarding article, "Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy".
    Pieroni M; Bellocci F; Crea F
    Circulation; 2007 Feb; 115(5):e67; author reply e68. PubMed ID: 17283273
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 10. Chloroquine neuromyotoxicity. Clinical and pathologic perspective.
    Estes ML; Ewing-Wilson D; Chou SM; Mitsumoto H; Hanson M; Shirey E; Ratliff NB
    Am J Med; 1987 Mar; 82(3):447-55. PubMed ID: 3826099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine cardiotoxicity.
    Piette JC; Guillevin L; Chapelon C; Wechsler B; Bletry O; Godeau P
    N Engl J Med; 1987 Sep; 317(11):710-1. PubMed ID: 3627179
    [No Abstract]   [Full Text] [Related]  

  • 12. Images in cardiovascular medicine. Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy.
    Reffelmann T; Naami A; Spuentrup E; Kühl HP
    Circulation; 2006 Aug; 114(8):e357-8. PubMed ID: 16923761
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythema annulare centrifugum due to hydroxychloroquine sulfate and chloroquine sulfate.
    Ashurst PJ
    Arch Dermatol; 1967 Jan; 95(1):37-9. PubMed ID: 6016304
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
    Wille F; Birkmeier S; Tiemann K; Lewalter T; Klingel K; Rabe C; Sick P
    Internist (Berl); 2020 Aug; 61(8):854-859. PubMed ID: 32504300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine-induced cardiomyopathy.
    McAllister HA; Ferrans VJ; Hall RJ; Strickman NE; Bossart MI
    Arch Pathol Lab Med; 1987 Oct; 111(10):953-6. PubMed ID: 2957973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.
    Yogasundaram H; Putko BN; Tien J; Paterson DI; Cujec B; Ringrose J; Oudit GY
    Can J Cardiol; 2014 Dec; 30(12):1706-15. PubMed ID: 25475472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular changes after treatment of chronic discoid lupus erythematosus with chloroquine.
    Handa F; Chopra A; Aggarwal RR; Bansal DC
    Indian J Dermatol; 1983 Oct; 28(4):145-8. PubMed ID: 6671702
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.
    Tselios K; Gladman DD; Harvey P; Mak S; Chantal M; Butany J; Urowitz MB
    J Clin Rheumatol; 2016 Aug; 22(5):287-8. PubMed ID: 27464781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.